Changfeng Pharmaceuticals (02652) announced its IPO from September 26 to October 2, planning to globally offer 41,198,000 H-shares; Zhongchuang Zhiling (00564) intends to invest in the construction of a new energy vehicle components industrial base and R&D center project.
Major Developments:
Changfeng Pharmaceuticals (02652) announced its initial public offering from September 26 to October 2, planning to globally offer 41,198,000 H shares.
Tong Ren Tang Chinese Medicine (03613) has been granted the Traditional Medicine Registration Certificate.
China Medical System Holdings (00867): Positive results achieved in Phase III clinical trials in China for the AD indication of the innovative drug Ruxolitinib Phosphate Cream.
Peijia Medical-B (09996): First patient treated in the multicenter registration clinical trial of the ReachTactile robotic-assisted TAVR system.
MINISO (09896) proposes to spin off TOP TOY and list it independently on the Main Board of the Hong Kong Stock Exchange.
Fosun Pharma (02196): Fosun Pharmaceutical Industry, a controlling subsidiary, plans to participate in establishing a private equity fund and intends to transfer 100% equity of Shanghai Clone.
Baiyunshan (00874): Guangzhou Pharmaceutical Phase II Fund to Acquire 11.04% Stake in Nanjing Pharmaceutical for RMB 7.488 billion.
China Innovation Wisdom Holdings (00564) plans to invest in the construction of a new energy vehicle components industrial base and research and development center project.
Hisense Home Appliances (00921) plans to acquire 26.0006% of the equity interest in Hisense (Guangdong) Kitchen & Bath System Co., Ltd. for RMB 94.2905 million.
Xinjiang Top Energy (01799) subsidiary proposes to acquire 100% equity of Xuyi Gaochuan for RMB 136.8 million.
Yuexiu Property's (00123) subsidiary intends to acquire 50.5% equity interest in Hangzhou Bind De Real Estate Development Co., Ltd.
Operating Performance:
China Power International (02380) reports total consolidated sales volume of approximately 11.7215 million megawatt-hours in August, representing a year-over-year increase of 4.78%.
Topsun Life Services (00331) announces annual results, with profit attributable to shareholders amounting to HKD 453 million, marking a year-over-year decrease of 9.6%.
Asia Pacific Resources (01104) announced its annual results, with shareholders' attributable profit of HKD 2.44 billion, representing a year-on-year decrease of 37.48%.
Dah Li Group (00029) announces annual results, reporting a net loss attributable to shareholders of HKD 62.594 million, shifting from profit to loss compared to the previous year.
